When Pain is a Psychological Signal: Somatoform Manifestations of Anxiety and Depression

When Pain is a Psychological Signal: Somatoform Manifestations of Anxiety and Depression

Chronic pain is a debilitating condition that significantly reduces quality of life. But what if the cause of physical suffering lies not only in the body, but also in the depths of our psyche? Somatoform pain represents precisely this phenomenon: when psychological distress manifests as physical symptoms in the absence of clear medical causes [4]. This is not "imagined" pain, but real sensations that can be closely linked to anxiety, depression, and chronic stress. Understanding this relationship is critical for effective diagnosis and treatment.

What is Somatoform Pain and How is it Related to the Psyche?

Somatization is the process by which emotional experiences, such as anxiety, depression, or stress, manifest as bodily symptoms. In somatoform pain, a person experiences real physical sensations that cannot be fully explained by known medical conditions, or the intensity and duration of the pain significantly exceed what would be expected from an existing disease [4].

Research shows a high prevalence of emotional disorders, including anxiety, chronic stress, and depression, among patients suffering from pain, especially in rheumatic diseases such as fibromyalgia [2]. Even in cancer patients, a significant portion of pain syndromes is not directly related to cancer, but has a somatoform component, often exacerbated by stress [3]. This emphasizes the profound connection between mind and body, where mental state can directly influence the perception and intensity of physical pain.

Pain, Depression, and Anxiety: Common Mechanisms

The relationship between pain, anxiety, and depression is not accidental. It is driven by shared pathogenetic mechanisms that affect the central nervous system and peripheral pain pathways:

• Central Sensitization (CS): This is a state in which the nervous system becomes hypersensitive to pain stimuli. In CS, normal, non-painful sensations can be perceived as pain, and painful stimuli as significantly more intense. This mechanism plays a key role in the development of chronic pain and is closely linked to somatization, especially in conditions such as temporomandibular disorders (TMD) [4].
• Neuroinflammation: Inflammatory processes in the nervous system can amplify pain signals and contribute to the development of migraine and other chronic pain syndromes. For example, systemic neuroinflammation induced by lipopolysaccharides enhances trigeminal afferent activity and exacerbates mechanical allodynia and photophobia in rat migraine models [8].
• Mitochondrial Dysfunction: Studies show that impaired mitochondrial function in the spinal cord may contribute to peripheral hypersensitivity in migraine [6]. This opens up new avenues for non-pharmacological treatment, such as hyperbaric oxygen therapy (HBOT), aimed at improving mitochondrial function [6].
• Calcitonin Gene-Related Peptide (CGRP): This neuropeptide plays an important role in transmitting pain signals, particularly in migraine. Studies in mice have shown that the CGRP receptor antagonist, atogepant, can reduce pain and anxiety-like behavior induced by cortical spreading depression, which is a probable cause of migraine aura [1].
• Serotonin: Alterations in the serotonergic system can also influence pain perception. Neuroinflammation can enhance serotonin-evoked trigeminal afferent activity, contributing to the development of migraine-like symptoms [8].

Somatoform Pain in Various Conditions

Somatoform manifestations of pain can occur in a wide range of diseases, worsening their course and complicating treatment:

• Rheumatic Diseases: Patients with rheumatic diseases, especially fibromyalgia, often exhibit a high prevalence of anxiety and depression. This is due to shared pathogenic mechanisms linking emotions and pain, which requires a comprehensive therapeutic approach [2].
• Temporomandibular Disorders (TMD): These common orofacial pain conditions are closely linked to somatization. A significant proportion of TMD patients demonstrate moderate to high levels of somatic symptoms, leading to increased pain, longer disease duration, and heightened psychological distress. Recognizing somatization in TMD is critical for successful treatment [4].
• Irritable Bowel Syndrome (IBS) and Ulcerative Colitis (UC): Somatic symptom disorder (SSD) is a relevant issue for patients with IBS and UC. Understanding the dynamics of SSD and its predictors in these conditions can aid in psychological treatment decisions [5].
• Migraine and Tension Headaches: These conditions often have a psychosomatic component. In addition to neurobiological mechanisms such as spreading depression [1], mitochondrial dysfunction [6], and neuroinflammation [8], stress plays a significant role in their onset and exacerbation. In cancer patients, tension headaches and migraines are frequently functional somatic syndromes not directly related to cancer, but exacerbated by stress [3].

Diagnosis and the Importance of a Comprehensive Approach

Recognizing somatoform pain requires a careful and comprehensive approach. It is important not only to exclude organic causes of pain, but also to actively identify the psychological component. This can be achieved using specialized tools and a thorough medical history [2].

Recognizing somatization in patients is crucial, as it can negatively impact treatment outcomes and requires the application of a biopsychosocial approach to condition management [4]. This approach considers the interaction of biological, psychological, and social factors influencing health and disease.

Using methods such as the "Armchair Sign," which assesses stress-related muscle tension, can help identify the role of stress in the development of pain syndromes, including in cancer patients [3].

Modern Approaches to Treatment

Effective treatment of somatoform pain requires the integration of various therapeutic strategies:

• Combined Pharmacotherapy: A combination of analgesics with antidepressants is often required, as they can modulate pain pathways and improve mood [2].
• Psychotherapeutic Strategies: Cognitive-behavioral therapy, relaxation techniques, and other forms of psychotherapy play a key role in managing stress, anxiety, and depression, thereby reducing the intensity of somatic symptoms [2, 5].
• Specific Medications: Targeted drugs are being developed for certain conditions. For example, CGRP receptor antagonists, such as atogepant, demonstrate efficacy in reducing pain and anxiety in migraine [1].
• Neuromodulation: Methods such as burst transspinal magnetic stimulation (bTsMS) show promising results in alleviating nociceptive pain. Although the study was conducted in Parkinson's disease patients, it also showed a positive effect on mood and quality of life [7].
• Hyperbaric Oxygen Therapy (HBOT): Studied as a potential non-pharmacological treatment for migraine aimed at correcting mitochondrial dysfunction [6].

Conclusion

Somatoform pain is a complex yet treatable condition that requires an interdisciplinary approach. Recognizing that physical pain can be a manifestation of anxiety or depression paves the way for more effective treatment strategies that account for both the physical and mental aspects of health. Comprehensive therapy, including medication, psychotherapy, and modern neuromodulatory methods, can significantly improve the quality of life of patients suffering from this form of pain.

References

• [1] Oral atogepant mitigates spreading depolarization-induced pain and anxiety behavior in mice. https://pubmed.ncbi.nlm.nih.gov/40841621/
• [2] Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management. https://pubmed.ncbi.nlm.nih.gov/24938201/
• [3] Prevalence and Stress Involvement of Myofascial Pain Syndrome Across Cancer Stages: A Multicenter Prospective Observational Study with Exploratory Analyses of Tension-Type Headache, Migraine, and the Armchair Sign. https://pubmed.ncbi.nlm.nih.gov/42539410/
• [4] Association between temporomandibular disorders and somatization: a narrative review. https://pubmed.ncbi.nlm.nih.gov/41607321/
• [5] Course and predictors of somatic symptom disorder in irritable bowel syndrome and ulcerative colitis: A longitudinal analysis from the SOMA.GUT-RCT. https://pubmed.ncbi.nlm.nih.gov/41833154/
• [6] Mitochondrial dysfunction in the spinal cord contributes to peripheral hypersensitivity in a nitroglycerin-induced migraine model. https://pubmed.ncbi.nlm.nih.gov/41507943/
• [7] Burst Transspinal Magnetic Stimulation Alleviates Nociceptive Pain in Parkinson Disease-A Pilot Phase II Double-Blind, Randomized Study. https://pubmed.ncbi.nlm.nih.gov/36411151/
• [8] LPS-Induced Neuroinflammation Increases Serotonin-Evoked Activity of Trigeminal Afferents and Aggravates Mechanical Allodynia and Photophobic Behavior in Rat Migraine Model. https://pubmed.ncbi.nlm.nih.gov/41465411/

Important Notice

The information in this article is for reference only and cannot replace an in-person consultation with a specialist. Always consult a qualified physician for diagnosis and treatment.